Detection of the New 'Cicada' Coronavirus Subvariant
A new Omicron-lineage coronavirus subvariant, designated BA.3.2 and nicknamed 'Cicada', has been identified by Ukraine's Public Health Center of the Ministry of Health. This subvariant was first detected in South Africa in November 2024 and has since been reported in at least 23 countries worldwide. According to the World Health Organization (WHO), the 'Cicada' subvariant currently shows no signs of posing an increased epidemiological risk. The emergence of new subvariants is a normal part of viral evolution, and global health bodies continue to monitor their characteristics.
Research and Symptoms
In Ukraine, samples for research are collected from healthcare facilities. Positive samples are sent to the Public Health Center laboratory for genomic sequencing and virus genotyping. The symptoms associated with the 'Cicada' subvariant are similar to those of other COVID-19 variants and include:
- Runny nose
- Fever
- Cough
- Headache
- Fatigue
- Loss of smell or taste
- Possible eye irritation and rashes
Ukraine is using an Omicron-specific vaccine, adapted to protect against the SARS-CoV-2 Omicron variant and its subvariants. The Ministry of Health has updated its coronavirus vaccination guidelines. Booster shots are recommended every 6-12 months for the following groups:
- Adults and children with weakened immune systems or underlying severe chronic conditions
- Pregnant women
- People over 60 years old
- Adults and children at risk of severe illness or death from coronavirus infection
Professional risk groups specifically include healthcare workers, teachers, and military personnel.
The detection of the new 'Cicada' coronavirus subvariant underscores the critical need for ongoing epidemic monitoring and the adaptation of preventive measures.
Public Health Center of the Ministry of Health of Ukraine
Given the constant evolution of viruses, it remains vital for the public to stay informed about symptoms and available vaccines to help curb the spread of infection. These updated booster recommendations reflect the Ministry of Health's efforts to safeguard the most vulnerable segments of the population.